Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide- carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer： a retrospective analysis of 62 cases

Objective： To compare the efficacy and adverse effects of paclitaxel-etoposide-carboplatin/cisplatin （TEP/TCE） regimen with those of etoposide-carboplatin/cisplatin （EP/CE） regimen as first-line treatment for combined small-cell lung cancer （CSCLC）. Methods： A retrospective study was conducted on 62...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer biology & medicine 2015-06, Vol.12 (2), p.117-125
Hauptverfasser:	Li, Yue-Ya, Zhou, Chan, Yang, Deng-Xia, Wang, Jing, Liu, Zhu-Jun, Wang, Xin-Yue, Li, Kai
Format:	Artikel
Sprache:	eng
Schlagworte:	Original TEP 卡铂 治疗方案 紫杉醇 细胞 肺癌 足叶乙甙 顺铂
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!